Where do we stand with screening for colorectal cancer and advanced adenoma based on serum protein biomarkers? A systematic review
Colorectal cancer (CRC) screening has been proven to reduce both mortality and the incidence of this disease. Most CRC screening programs are based on fecal immunochemical tests (FITs), which have a low participation rate. Searching for blood protein biomarkers can lead to the development of a more...
Saved in:
| Main Authors: | Adrien Grancher, Steven Cuissy, Hélène Girot, André Gillibert, Frédéric Di Fiore, Lydia Guittet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.13734 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The diagnostic value of serum Ephrin-A1 in patients with colorectal cancer
by: Qi-Xin Su, et al.
Published: (2024-12-01) -
Associations of serum and tissue TIMP1 with host response and survival in colorectal cancer
by: Akseli Kehusmaa, et al.
Published: (2025-01-01) -
Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer
by: Shunsuke Sakuraba, et al.
Published: (2024-11-01) -
Soluble galectin-4 in colorectal cancer is associated with tumor progression, but is not a predictor of the disease outcome
by: Elena Y. Yakunina, et al.
Published: (2024-12-01) -
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
by: Alexander Siebenhüner
Published: (2020-10-01)